Health Care & Life Sciences » Pharmaceuticals | Nascent Biotech Inc.

Nascent Biotech Inc.

Nascent Biotech Inc.
Stock Exchange Other OTC
Market Cap
$5.6 M
Shares Outstanding
32.17 M
Public Float
23.99 M


601 21st Street
Vero Beach Florida 32960
United States
Employees -
Updated 07/08/2019
Nascent Biotech, Inc. is a clinical-stage biopharmaceutical company, which develops monoclonal antibodies for the treatment of various forms of cancer. It focuses on biologic drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seek to further develop those drug candidates for commercial use. The company was founded in July 15, 2014 and is headquartered in Vero Beach, FL.


View All

Sean Carrick
President, CEO, Secretary & Director
Lowell Thomas Holden
Director, Chief Financial & Accounting Officer